The purpose of this proposal is to secure funds to support training and career development for Dr. Doris Molina- Henry as a new independent investigator through the Research Supplements to Promote Diversity in Health- Related Research Program (PA 18-586). This application seeks funding through an administrative research supplement to the Wake Forest Alzheimer?s Disease Research Center (ADRC: P30 AG049638-02; PI: Dr. Suzanne Craft). The proposed request is intended to provide resources and training to support the career development of Dr. Molina-Henry, an early-stage investigator. Dr. Molina-Henry will be provided with intensive training through her involvement in ongoing ADRC activities and through the conduct of an independent study focused on biomarker discovery in the Clinical Core cohort, which will complement the aims of the parent grant. The overall goal of the training plan will be to expand Dr. Molina-Henry?s basic science training into fields critical to translational science in aging and Alzheimer?s disease (AD) research. The focus of her career development training program will include 1) clinical trial conduct and cognitive assessment, 2) human brain imaging, 3) biomarker discovery, and 4) biostatistics. These skills will enhance her ability to conduct exploratory research in the area of biomarker discovery. The proposed independent exploratory study will investigate vascular biomarkers linked to AD by leveraging rich ADRC data resources and examining relationships between biomarkers and other available specimen data, peripheral markers of vascular and metabolic health and cognition. Furthermore, biomarker data will also be related to brain imaging outcomes. Successful accomplishment of the activities proposed in this Diversity Supplement will allow Dr. Molina-Henry to gain valuable training and experience in performing, analyzing and interpreting molecular biomarker assays, analysis and interpretation of a variety of neuroimaging applications, development and execution of clinical trial research, as well as the statistical tools to accurately analyze clinical trial data.
Successful accomplishment of the activities proposed in this Diversity Supplement will allow Dr. Doris Molina- Henry, Assistant Professor at Winston-Salem State University, to gain valuable training and experience in performing, analyzing and interpreting molecular biomarker assays, analysis and interpretation of a variety of neuroimaging applications, development and execution of clinical trial research, as well as the statistical tools to accurately analyze clinical trial data.
|Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104|
|Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826|
|Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124|
|Brenowitz, Willa D; Han, Fang; Kukull, Walter A et al. (2018) Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiol Aging 62:64-71|
|Gallagher, Damien; Kiss, Alex; Lanctot, Krista L et al. (2018) Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors. J Clin Psychiatry 80:|
|Espeland, Mark A; Carmichael, Owen; Yasar, Sevil et al. (2018) Sex-related differences in the prevalence of cognitive impairment among overweight and obese adults with type 2 diabetes. Alzheimers Dement 14:1184-1192|
|Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642|
|Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827|
|Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064|
|Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10|
Showing the most recent 10 out of 34 publications